These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1425 related articles for article (PubMed ID: 12881481)

  • 41. Selective antagonism of the AT1 receptor inhibits the effect of angiotensin II on DNA and protein synthesis of rat proximal tubular cells.
    Weerackody RP; Chatterjee PK; Mistry SK; McLaren J; Hawksworth GM; McLay JS
    Exp Nephrol; 1997; 5(3):253-62. PubMed ID: 9208286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
    Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ
    Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
    Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
    Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The effect of angiotensin II on phosphoinositide-3 kinase/Akt cascade in cultured fibroblasts derived from patients with hypertrophic scars].
    Liu HW; Cheng B; Wu HJ; Gu YF; Chen X; Chen ZG; Liu WZ
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2010 Jan; 26(1):57-60. PubMed ID: 20432929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rho family GTPases regulate VEGF-stimulated endothelial cell motility.
    Soga N; Namba N; McAllister S; Cornelius L; Teitelbaum SL; Dowdy SF; Kawamura J; Hruska KA
    Exp Cell Res; 2001 Sep; 269(1):73-87. PubMed ID: 11525641
    [TBL] [Abstract][Full Text] [Related]  

  • 46. VEGF protects bovine aortic endothelial cells from TNF-alpha- and H2O2-induced apoptosis via co-modulatory effects on p38-and p42/p44-CCDPK signaling.
    Liu WL; Guo X; Chen QQ; Guo ZG
    Acta Pharmacol Sin; 2002 Jan; 23(1):45-9. PubMed ID: 11860736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Goniodomin A, an antifungal polyether macrolide, exhibits antiangiogenic activities via inhibition of actin reorganization in endothelial cells.
    Abe M; Inoue D; Matsunaga K; Ohizumi Y; Ueda H; Asano T; Murakami M; Sato Y
    J Cell Physiol; 2002 Jan; 190(1):109-16. PubMed ID: 11807817
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiotensin AT1 receptor upregulates expression of basic fibroblast growth factor, basic fibroblast growth factor receptor and coreceptor in human coronary smooth muscle cells.
    Skaletz-Rorowski A; Pinkernell K; Sindermann JR; Schriever C; Müller JG; Eschert H; Breithardt G
    Basic Res Cardiol; 2004 Jul; 99(4):272-8. PubMed ID: 15221345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion.
    Keledjian K; Garrison JB; Kyprianou N
    J Cell Biochem; 2005 Feb; 94(2):374-88. PubMed ID: 15526277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins.
    Gingras D; Lamy S; Béliveau R
    Biochem J; 2000 Jun; 348 Pt 2(Pt 2):273-80. PubMed ID: 10816419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein kinase C-mediated inhibition of renal Ca2+ ATPase by physiological concentrations of angiotensin II is reversed by AT1- and AT2-receptor antagonists.
    Assunção-Miranda I; Guilherme AL; Reis-Silva C; Costa-Sarmento G; Oliveira MM; Vieyra A
    Regul Pept; 2005 Apr; 127(1-3):151-7. PubMed ID: 15680481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin II-induced relaxation of anococcygeus smooth muscle via desensitization of AT1 receptor, and activation of AT2 receptor associated with nitric-oxide synthase pathway.
    de Godoy MA; de Oliveira AM; Rattan S
    J Pharmacol Exp Ther; 2004 Oct; 311(1):394-401. PubMed ID: 15178697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
    Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
    J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Regulating effects of VEGF and ANG II on the frog's pericardial mesothelium, stomata, and angiogenesis].
    Li J; Zhou J; Tota B; Scalia G; Gattuso A
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):350-5. PubMed ID: 12567432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pigment-epithelium-derived factor (PEDF) inhibits angiotensin-II-induced vascular endothelial growth factor (VEGF) expression in MOLT-3 T cells through anti-oxidative properties.
    Yamagishi S; Matsui T; Nakamura K; Yoshida T; Shimizu K; Takegami Y; Shimizu T; Inoue H; Imaizumi T
    Microvasc Res; 2006 May; 71(3):222-6. PubMed ID: 16624340
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for a functional role of angiotensin II type 2 receptor in the cardiac hypertrophic process in vivo in the rat heart.
    Lakó-Futó Z; Szokodi I; Sármán B; Földes G; Tokola H; Ilves M; Leskinen H; Vuolteenaho O; Skoumal R; deChâtel R; Ruskoaho H; Tóth M
    Circulation; 2003 Nov; 108(19):2414-22. PubMed ID: 14568903
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
    Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
    Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
    Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
    Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro.
    Montesano R; Kumar S; Orci L; Pepper MS
    Lab Invest; 1996 Aug; 75(2):249-62. PubMed ID: 8765325
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts.
    Sasaoka T; Egi Y; Tawa M; Yamamoto A; Ohkita M; Takaoka M; Maruyama T; Akira T; Matsumura Y
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):176-83. PubMed ID: 18670361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.